TNFRSF11A
Tumor necrosis factor receptor superfamily member 11A
Also known as: CD265, FEO, LOH18CR1, ODFR, PDB2, RANK, TNR11_HUMAN, TRANCE-R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6Q6
- Gene
- TNFRSF11A
- Ensembl
- ENSG00000141655
- Chromosome
- 18
- Canonical length
- 616 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptors can interact with various TRAF family proteins, through which this receptor induces the activation of NF-kappa B and MAPK8/JNK. This receptor and its ligand are important regulators of the interaction between T cells and dendritic cells. This receptor is also an essential mediator for osteoclast and lymph node development. Mutations at this locus have been associated with familial expansile osteolysis, autosomal recessive osteopetrosis, and Paget disease of bone. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Aug 2012]
Canonical amino-acid sequenceUniProt
616 residues, UniProt reviewed canonical sequence.
>Q9Y6Q6|TNFRSF11A
1 MAPRARRRRP LFALLLLCAL LARLQVALQI APPCTSEKHY EHLGRCCNKC EPGKYMSSKC
61 TTTSDSVCLP CGPDEYLDSW NEEDKCLLHK VCDTGKALVA VVAGNSTTPR RCACTAGYHW
121 SQDCECCRRN TECAPGLGAQ HPLQLNKDTV CKPCLAGYFS DAFSSTDKCR PWTNCTFLGK
181 RVEHHGTEKS DAVCSSSLPA RKPPNEPHVY LPGLIILLLF ASVALVAAII FGVCYRKKGK
241 ALTANLWHWI NEACGRLSGD KESSGDSCVS THTANFGQQG ACEGVLLLTL EEKTFPEDMC
301 YPDQGGVCQG TCVGGGPYAQ GEDARMLSLV SKTEIEEDSF RQMPTEDEYM DRPSQPTDQL
361 LFLTEPGSKS TPPFSEPLEV GENDSLSQCF TGTQSTVGSE SCNCTEPLCR TDWTPMSSEN
421 YLQKEVDSGH CPHWAASPSP NWADVCTGCR NPPGEDCEPL VGSPKRGPLP QCAYGMGLPP
481 EEEASRTEAR DQPEDGADGR LPSSARAGAG SGSSPGGQSP ASGNVTGNSN STFISSGQVM
541 NFKGDIIVVY VSQTSQEGAA AAAEPMGRPV QEETLARRDS FAGNGPRFPD PCGGPEGLRE
601 PEKASRPVQE QGGAKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF11A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 29 nTPM
- salivary gland: 24 nTPM
- small intestine: 17 nTPM
- rectum: 16 nTPM
- colon: 15 nTPM
- gallbladder: 7.1 nTPM
Single-cell type
- salivary acinar cells: 97 nCPM
- lacrimal acinar cells: 85 nCPM
- enteric stem cells: 67 nCPM
- lactotrophs: 64 nCPM
- lymphatic endothelial cells: 64 nCPM
- colonocytes: 61 nCPM
Immune cell
- NK-cell: 2.3 nTPM
- T-reg: 0.2 nTPM
- neutrophil: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 4.5 nTPM
- white matter: 4.3 nTPM
- basal ganglia: 3.7 nTPM
- thalamus: 3.3 nTPM
- midbrain: 3.2 nTPM
- amygdala: 2.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TNFRSF11A.
Disease | AllUniProt
Conditions TNFRSF11A is implicated in, by any mechanism.
- Familial expansile osteolysis (FEO) MIM:174810
- Paget disease of bone 2, early-onset (PDB2) MIM:602080
- Osteopetrosis, autosomal recessive 7 (OPTB7) MIM:612301
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 791 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive osteopetrosis 7
- Familial expansile osteolysis
- Paget disease of bone 2, early-onset
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.29
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cell-cell signaling
- cellular response to zinc ion starvation
- circadian temperature homeostasis
- lymph node development
- mammary gland alveolus development
- monocyte chemotaxis
- multinuclear osteoclast differentiation
- ossification
- osteoclast differentiation
- positive regulation of bone resorption
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell population proliferation
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of fever generation by positive regulation of prostaglandin secretion
- positive regulation of JNK cascade
- positive regulation of non-canonical NF-kappaB signal transduction
- positive regulation of osteoclast differentiation
- response to ethanol
- response to insulin
- response to interleukin-1
- response to lipopolysaccharide
- response to mechanical stimulus
- response to tumor necrosis factor
- signal transduction
- tumor necrosis factor-mediated signaling pathway
Molecular functions
- cytokine binding
- metal ion binding
- signaling receptor activity
- transmembrane signaling receptor activity
- tumor necrosis factor receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TNFR/NGFR cysteine-rich region
- Tumour necrosis factor receptor 11
- TNFR/NGFR cysteine-rich region
- Tumour necrosis factor receptor 11A
- Tumor necrosis factor receptor 11A, N-terminal
- Rank, cysteine-rich repeat domain 2
- Tumor necrosis factor receptor superfamily member 11A
- Receptor activator of the NF-KB cysteine-rich repeat domain 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF11A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF11A as an antibody target. Whether an autoantibody or antibody against TNFRSF11A could matter depends on whether native TNFRSF11A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF11A is annotated at the cell surface, where native TNFRSF11A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFRSF11A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...